Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is a common genetic disorder affecting around 400 million people worldwide. Rapid diagnosis using the FINDER G6PD test ensures timely intervention, improving patient outcomes and saving healthcare resources and healthcare costs.
FDA-cleared and CE-marked FINDER G6PD test provides glucose 6-phosphate dehydrogenase enzymatic activity in whole blood specimens using only a 50 microliter sample, enabling clinicians to quickly and accurately determine G6PDd status. Rapid time to result of ≅ 17 minutes Simple workflow with no sample preparation Lab-equivalent performance of <5% CV Small footprint – the size of an A4 sheet of paper. FINDER G6PD Test is CE-marked and US FDA cleared.
Any Test. Anywhere. Everyone.™
FINDER® Near-Patient Testing Platform for G6PD Deficiency
FINDER G6PD Test
*Latest Model of FINDER is not available for sale or use in any territory.
It has made a difference in the practice at our hospital. The ability to get a quantitative or semiquantitative value within 24 hours has made a difference in patient care, we really do appreciate this instrument.
Director, Hematology & Coagulation Laboratory
Baebies pricing structure and its technology platform were the primary drivers for pursuing the FINDER device.
Director, Clinical Chemistry Laboratory
4 Simple Steps for Fast, Accurate G6PD Testing
Quick, efficient, and reliable—enabling immediate care and better patient outcomes. See how easy it is and why many hospitals are adopting it —watch the video now!